Prospective Observational Epidemiologic Study of Maraviroc's Safety

NCT00665561 · clinicaltrials.gov ↗

COMPLETED

Status

2500

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: Maraviroc along with an optimized background antiretroviral drug regimen
DRUG: Optimized background antiretroviral drug regimen without maraviroc

Sponsor

ViiV Healthcare

Collaborators

[object Object]